| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | uridine | 341 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 448 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 814 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 975 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 1014 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 7 |
| GC POSITIVE ION MODE | uridine | 1139 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 1193 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 1272 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 1393 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 1591 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 1648 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 1697 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 1717 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 1791 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 1810 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 1859 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 1865 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 2053 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 2081 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2099 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2153 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 2159 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 2174 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 2203 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2282 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 2293 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 3 |
| GC POSITIVE ION MODE | uridine | 2312 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 2421 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2524 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2562 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2667 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2698 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2715 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2726 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 2747 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 2870 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | uridine | 2920 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 7 |
| GC POSITIVE ION MODE | uridine | 2937 | Counts | Synbiotic | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 3010 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 3072 | Counts | Placebo | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 3150 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 3207 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 3417 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 3497 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 3622 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 3654 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 3806 | Counts | Placebo | Recovery (days 631-633) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 3944 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 3971 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | uridine | 4289 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 3 |
| GC POSITIVE ION MODE | uridine | 4607 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 4785 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 6 |
| GC POSITIVE ION MODE | uridine | 4801 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 4913 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 6 |
| GC POSITIVE ION MODE | uridine | 5500 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 3 |
| GC POSITIVE ION MODE | uridine | 5785 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 5 |
| GC POSITIVE ION MODE | uridine | 6912 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 8 |
| GC POSITIVE ION MODE | uridine | 36466 | Counts | Synbiotic | Recovery (days 631-633) | Male castrated | 3 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|